325 related articles for article (PubMed ID: 20181807)
1. Review of muscle wasting associated with chronic kidney disease.
Workeneh BT; Mitch WE
Am J Clin Nutr; 2010 Apr; 91(4):1128S-1132S. PubMed ID: 20181807
[TBL] [Abstract][Full Text] [Related]
2. Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact.
Rajan VR; Mitch WE
Pediatr Nephrol; 2008 Apr; 23(4):527-35. PubMed ID: 17987322
[TBL] [Abstract][Full Text] [Related]
3. Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure.
Mitch WE
J Ren Nutr; 2006 Jul; 16(3):208-11. PubMed ID: 16825021
[TBL] [Abstract][Full Text] [Related]
4. Muscle wasting from kidney failure-a model for catabolic conditions.
Wang XH; Mitch WE
Int J Biochem Cell Biol; 2013 Oct; 45(10):2230-8. PubMed ID: 23872437
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin.
Thomas SS; Mitch WE
Clin Exp Nephrol; 2013 Apr; 17(2):174-82. PubMed ID: 23292175
[TBL] [Abstract][Full Text] [Related]
6. Strategies for suppressing muscle atrophy in chronic kidney disease: mechanisms activating distinct proteolytic systems.
Mitch WE; Hu Z; Lee SW; Du J
J Ren Nutr; 2005 Jan; 15(1):23-7. PubMed ID: 15648002
[TBL] [Abstract][Full Text] [Related]
7. XIAP reduces muscle proteolysis induced by CKD.
Hu J; Du J; Zhang L; Price SR; Klein JD; Wang XH
J Am Soc Nephrol; 2010 Jul; 21(7):1174-83. PubMed ID: 20431038
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of muscle wasting in chronic kidney disease.
Wang XH; Mitch WE
Nat Rev Nephrol; 2014 Sep; 10(9):504-16. PubMed ID: 24981816
[TBL] [Abstract][Full Text] [Related]
9. [Muscle-wasting in end stage renal disease in dialysis treatment: a review].
Battaglia Y; Galeano D; Cojocaru E; Fiorini F; Forcellini S; Zanoli L; Storari A; Granata A
G Ital Nefrol; 2016; 33(2):. PubMed ID: 27067216
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling.
Wang X; Hu Z; Hu J; Du J; Mitch WE
Endocrinology; 2006 Sep; 147(9):4160-8. PubMed ID: 16777975
[TBL] [Abstract][Full Text] [Related]
11. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process.
Du J; Hu Z; Mitch WE
Int J Biochem Cell Biol; 2005 Oct; 37(10):2147-55. PubMed ID: 15982920
[TBL] [Abstract][Full Text] [Related]
12. Malnutrition is an unusual cause of decreased muscle mass in chronic kidney disease.
Mitch WE
J Ren Nutr; 2007 Jan; 17(1):66-9. PubMed ID: 17198936
[TBL] [Abstract][Full Text] [Related]
13. Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease.
Rajan V; Mitch WE
Biochim Biophys Acta; 2008 Dec; 1782(12):795-9. PubMed ID: 18723090
[TBL] [Abstract][Full Text] [Related]
14. Molecular signaling pathways regulating muscle proteolysis during atrophy.
Franch HA; Price SR
Curr Opin Clin Nutr Metab Care; 2005 May; 8(3):271-5. PubMed ID: 15809529
[TBL] [Abstract][Full Text] [Related]
15. The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulation.
Bilodeau PA; Coyne ES; Wing SS
Am J Physiol Cell Physiol; 2016 Sep; 311(3):C392-403. PubMed ID: 27510905
[TBL] [Abstract][Full Text] [Related]
16. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome.
Sandri M
Int J Biochem Cell Biol; 2013 Oct; 45(10):2121-9. PubMed ID: 23665154
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin-proteasome system and skeletal muscle wasting.
Attaix D; Ventadour S; Codran A; Béchet D; Taillandier D; Combaret L
Essays Biochem; 2005; 41():173-86. PubMed ID: 16250905
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of skeletal muscle atrophy.
Ventadour S; Attaix D
Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
[TBL] [Abstract][Full Text] [Related]
19. Transgenic overexpression of locally acting insulin-like growth factor-1 inhibits ubiquitin-mediated muscle atrophy in chronic left-ventricular dysfunction.
Schulze PC; Fang J; Kassik KA; Gannon J; Cupesi M; MacGillivray C; Lee RT; Rosenthal N
Circ Res; 2005 Sep; 97(5):418-26. PubMed ID: 16051886
[TBL] [Abstract][Full Text] [Related]
20. Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure.
Cunha TF; Bacurau AV; Moreira JB; Paixão NA; Campos JC; Ferreira JC; Leal ML; Negrão CE; Moriscot AS; Wisløff U; Brum PC
PLoS One; 2012; 7(8):e41701. PubMed ID: 22870245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
